Myogenic cells applications in regeneration of post-infarction cardiac tissue

Journal of Physiology and Pharmacology

Volumn 64, Issue 4, 2013, Pages 401-408

  Ciecierska, A ^a   Chodkowska, K ^a   Motyl, T ^a   Sadkowski, Tomasz ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Myocardial infarction; Myocardium regeneration; Post infarction regeneration; Skeletal myoblasts; Stem cell therapy

Indexed keywords

CARDIAC TISSUE REGENERATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL TYPE; DEATH; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; HOST; HUMAN; IN VITRO STUDY; ISCHEMIA; MYOBLAST; NONHUMAN; PHENOTYPE; POST INFARCTION SCAR; REVIEW; SCAR; SKELETAL MYOBLAST TRANSPLANTATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ANIMALS; GENETIC THERAPY; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION;

EID: 84884944751     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Czarnowska E, Gajerska-Dzieciatkowska M, Kusmierski K, et al. Expression of SDF-1-CXCR4 axis and an antiremodelling effectiveness of foetal-liver stem cell transplantation in the infarcted rat heart. J Physiol Pharmacol 2007; 58: 729-744.
2. Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003; 92: 139-150.
3. Seidel M, Borczynska A, Rozwadowska N, Kurpisz M. Cellbased therapy for heart failure: skeletal myoblasts. Cell Transplant 2009; 18: 695-707.
4. Nilsson JC, Groenning BA, Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J 2002; 143: 696-702.
5. Taylor DA. Cell-based myocardial repair: how should we proceed? Int J Cardiol 2004; 95(Suppl. 1): S8-S12.
6. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 2003; 58: 351-357.
7. Zhang F, Pasumarthi KB. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs 2008; 22: 361-374.
8. Bialas M, Krupka M, Janeczek A, et al. Transient and stable transfections of mouse myoblasts with genes coding for proangiogenic factors. J Physiol Pharmacol 2011; 62: 219-228.
9. Burdzinska A, Berwid S, Orzechowski A. Muscle cell transplantations: the ups and downs. Post Hig Med Dosw 2005; 59: 299-308.
10. Perumal Srinivasan S, Neef K, Treskes P, et al. Enhanced gap junction expression in myoblast-containing engineered tissue. Biochem Biophys Res Commun 2012; 422: 462-468.
11. Uchinaka A, Kawaguchi N, Hamada Y, et al. Transplantation of elastin-secreting myoblast sheets improves cardiac function in infarcted rat heart. Mol Cell Biochem 2012; 368: 203-214.
12. Pelacho B, Nakamura Y, Zhang J, et al. Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J Tissue Eng Regen Med 2007; 1: 51-59.
13. Shintani Y, Fukushima S, Varela-Carver A, et al. Donor celltype specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol 2009; 47: 288-295.
14. Nakamura Y, Asakura Y, Piras BA, et al. Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium. PLoS One 2012; 7: e41736.
15. Laflamme MA, Murry CE. Heart regeneration. Nature 2011; 473: 326-335.
16. Siminiak T, Kalmucki P, Kurpisz M. Autologous skeletal myoblasts for myocardial regeneration. J Interv Cardiol 2004; 17: 357-365.
17. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001; 91: 534-551.
18. Grounds MD, White JD, Rosenthal N, Bogoyevitch, MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 2002; 50: 589-610.
19. Burdzinska A, Gala K, Paczek L. Myogenic stem cells. Folia Histochem Cytobiol 2008; 46: 401-412.
20. Zammit PS, Partridge TA, Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 2006; 54: 1177-1191.
21. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002; 9: 642-647.
22. 2-induced oxidative stress. Comp Med 2006; 56: 493-501.
23. Siminiak T, Meliga E, Jerzykowska O, Serruys PW. Percutaneous transplantation of skeletal myoblast in the treatment of post-infarction injury. Eur Heart J 2006; 8(Suppl.): H57-H64.
24. Bartoszuk-Bruzzone U, Burdzinska A, Orzechowski A, Klos Z. Protective effect of sodium ascorbate on efficacy of intramuscular transplantation of autologous muscle-derived cells. Muscle Nerve 2012; 45: 32-38.
25. Menasche P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 2008; 45: 545-553.
26. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-1083.
27. Zhang F, Yang Z, Chen Y, et al. Clinical cellular cardiomyoplasty: technical considerations. J Card Surg 2003; 18: 268-273.
28. Dib N, McCarthy P, Campbell A, et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 2005; 14: 11-19.
29. Siminiak T, Kalawski R, Fiszer D, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004; 148: 531-537.
30. Hagege AA, Marolleau JP, Vilquin JT, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006; 114(Suppl. 1): I108-I113.
31. Menasche P, Alfieri O, Janssens S, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial. First randomized placebo-controlled study of myoblast transplantation. Ciculation 2008; 117: 1189-1200.
32. Steendijk P, Tulner SA, Bax JJ, et al. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation 2006; 113: 1295-1304.
33. Witkowski TG, ten Brinke EA, Delgado V, et al. Surgical ventricular restoration for patients with ischemic heart failure: determinants of two-year survival. Ann Thorac Surg 2011; 91: 491-498.
34. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34: 241-249.
35. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003; 100: 7808-7811.
36. Fernandes S, Amirault JC, Lande G, et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 2006; 69: 348-358.
37. Gandolfi F, Vanelli A, Pennarossa G, Rahaman M, Acocella F, Brevini TA. Large animal models for cardiac stem cell therapies. Theriogenology 2011; 75: 1416-1425.
38. Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: is it arrhythmogenic? J Am Coll Cardiol 2003; 42: 2070-2072.
39. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000; 149: 731-740.
40. Formigli L, Francini F, Tani A, et al. Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am J Physiol Cell Physiol 2005; 288: C795-C804.
41. Abraham MR, Henrikson CA, Tung L, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005; 97: 159-167.
42. Iijima Y, Nagai T, Mizukami M, et al. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J 2003; 17: 1361-1363.
43. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin43-expressing cells prevents post-infarct arrhythmia. Nature 2007; 450: 819-824.
44. Fernandes S, van Rijen HV, Forest V, et al. Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias. J Cell Mol Med 2009; 13: 3703-3712.
45. Suzuki K, Brand NJ, Allen S, et al. Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J Thorac Cardiovasc Surg 2001; 122: 759-766.
46. Tolmachov O, Ma YL, Themis M, et al. Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc Disord 2006; 6: 25.
47. Zhang H, Landmann F, Zahreddine H, Rodriguez D, Koch M, Labouesse M. A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 2011; 471: 99-103.
48. Rissanen TT, Markkanen JE, Arve K, et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 2003; 17: 100-102.
49. Rissanen TT, Korpisalo P, Markkanen JE, et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2005; 122: 3937-3946.
50. Askari A, Unzek S, Goldman CK, et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 2004; 43: 1908-1914.
51. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 2001; 104(Suppl. 1): I218-I222.
52. Yau TM, Li G, Weisel R, et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J Thorac Cardiovasc Surg 2004; 127: 1180-1187.
53. Xia JH, Xie AN, Zhang KL, Xu L, Zheng XY. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J 2006; 119: 117-121.
54. Tambara K, Tabata Y, Komeda M. Factors related to the efficacy of skeletal muscle cell transplantation and future approaches with control-released cell growth factors and minimally invasive surgery. Int J Cardiol 2004; 95(Suppl. 1): S13-S15.
55. Niagara MI, Haider HKh, Jiang S, et al. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007; 100: 545-555.
56. Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004; 18: 1153-1155.
57. Burdzinska A, Bartoszuk U, Orzechowski A. Preincubation with bFGF but not sodium ascorbate improves efficiency of autologous transplantation of muscle-derived cells into urethral wall. Urology 2009; 73: 736-742.
58. Hirai H, Verma M, Watanabe S, Tastad C, Asakura Y, Asakura A. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J Cell Biol 2010; 191: 347-365.
59. Hata H, Matsumiya G, Miyagawa S, et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacinginduced canine heart failure model. J Thorac Cardiovasc Surg 2006; 132: 918-924.
60. Kondoh H, Sawa Y, Miyagawa S, et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res 2006; 69: 466-475.
61. Memon IA, Sawa Y, Fukushima N, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005; 130: 1333-1341.
62. Hoashi T, Matsumiya G, Miyagawa S, et al. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J Thorac Cardiovasc Surg 2009; 138: 460-467.
63. Sekiya N, Matsumiya G, Miyagawa S, et al. Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J Thorac Cardiovasc Surg 2009; 138: 985-993.
64. Premaratne GU, Tambara K, Fujita M, et al. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ J 2006; 70: 1184-1189.